EFAX - ETF AI Analysis
Top Page
SPDR MSCI EAFE Fossil Fuel Free ETF (EFAX)
Rating:66Neutral
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the year and in recent months, indicating generally strong momentum.
Strong Leading Holdings
Several of the largest positions, such as ASML and major global banks, have delivered strong year-to-date performance, helping support the fund’s returns.
Broad International Diversification
The fund spreads its investments across many countries and sectors outside the U.S., which helps reduce the impact of problems in any single market or industry.
Negative Factors
Moderate Concentration in Top Stocks
The biggest holdings make up a noticeable share of the portfolio, so weakness in these companies could weigh on overall results.
Some Lagging Health Care Exposure
AstraZeneca, one of the top health care holdings, has shown weak performance year-to-date, which slightly offsets strength from other positions in the sector.
Focused on Developed Markets
The ETF is heavily tilted toward developed countries like Japan, the UK, and Europe, offering limited exposure to faster-growing emerging markets.
EFAX vs. SPDR S&P 500 ETF (SPY)
AUM515.23M
RegionDeveloped Markets
Expense Ratio0.20%
Beta0.79
IssuerState Street
Inception DateOct 24, 2016
Dividend Yield3.03%
Asset ClassEquity
Index TrackedMSCI EAFE ex Fossil Fuels
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume28,630
30 Day Avg. Volume22,193
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
63.56Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering633
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EFAX Summary
EFAX is an ETF that follows the MSCI EAFE ex Fossil Fuels Index, giving you broad exposure to major companies in Europe, Asia, and other developed markets outside North America while avoiding firms involved in fossil fuel extraction and production. It holds well-known names like Nestlé, Novartis, and HSBC, and spreads your money across many countries and sectors, which can help with diversification and long-term growth. A key risk is that its value can go up and down with global stock markets, and its fossil-fuel-free focus may cause it to perform differently from traditional international funds.
How much will it cost me?The SPDR MSCI EAFE Fossil Fuel Free ETF (EFAX) has an expense ratio of 0.20%, which means you’ll pay $2 per year for every $1,000 invested. This is lower than average for actively managed funds but slightly higher than many passively managed ETFs because it tracks a specialized index focused on sustainability.
What would affect this ETF?The EFAX ETF could benefit from increasing global demand for sustainable investments and the growth of developed markets outside North America, particularly in sectors like financials and technology, which have significant weight in the fund. However, challenges such as economic slowdowns in Europe or Asia, regulatory changes affecting key industries, or currency fluctuations in non-North American markets could negatively impact performance. Additionally, its exclusion of fossil fuel companies may limit exposure to potential gains in the energy sector during periods of high oil prices.
EFAX Top 10 Holdings
EFAX leans heavily on a handful of global champions, with ASML acting as a key engine of long‑term gains despite some recent wobbling. Financials are another big driver: HSBC and Mitsubishi UFJ have been rising, giving the fund a lift, while Banco Santander has been more mixed, occasionally tapping the brakes. On the defensive side, health care names like Roche and Novartis have been steady contributors, even as AstraZeneca has lost some steam. Overall, this is a diversified, developed‑markets ex‑North America play with a clear tilt toward banks and European blue chips, all screened to avoid fossil fuel producers.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.24% | $16.64M | €572.60B | 143.26% | 76 Outperform | |
| HSBC Holdings | 1.71% | $8.78M | £262.77B | 60.76% | 80 Outperform | |
| Roche Holding AG | 1.53% | $7.89M | $361.51B | 51.16% | 73 Outperform | |
| Novartis AG | 1.37% | $7.05M | CHF230.61B | 32.06% | 80 Outperform | |
| Nestlé SA | 1.24% | $6.40M | CHF208.89B | 10.64% | 71 Outperform | |
| AstraZeneca | 1.17% | $6.00M | $249.26B | 8.64% | 80 Outperform | |
| Mitsubishi UFJ Financial Group | 1.16% | $5.96M | ¥39.85T | 52.16% | 76 Outperform | |
| Siemens | 1.15% | $5.93M | €213.28B | 22.18% | 74 Outperform | |
| SAP SE | 1.03% | $5.30M | €207.78B | -27.93% | 66 Neutral | |
| Banco Santander | 1.02% | $5.26M | €188.68B | 54.02% | 73 Outperform |
EFAX Technical Analysis
Positive
―
Price Trends
54.13
Positive
52.85
Positive
51.53
Positive
Market Momentum
0.67
Negative
65.47
Neutral
86.69
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFAX, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 54.78, equal to the 50-day MA of 54.13, and equal to the 200-day MA of 51.53, indicating a bullish trend. The MACD of 0.67 indicates Negative momentum. The RSI at 65.47 is Neutral, neither overbought nor oversold. The STOCH value of 86.69 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EFAX.
EFAX Peer Comparison
Comparison Results
Performance Comparison
EFAX
SPDR MSCI EAFE Fossil Fuel Free ETF
56.38
9.52
20.32%
JHMD
John Hancock Multifactor Developed International ETF
―
―
―
DMXF
iShares ESG Advanced MSCI EAFE ETF
―
―
―
IQDG
WisdomTree International Quality Dividend Growth Fund
―
―
―
NUDM
Nuveen ESG International Developed Markets Equity ETF
―
―
―
DWM
WisdomTree International Equity Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents